VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 74 filers reported holding VERVE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,482,166 | -29.1% | 187,192 | +0.2% | 0.00% | 0.0% |
| Q2 2023 | $3,502,218 | +41.9% | 186,785 | +9.1% | 0.00% | 0.0% |
| Q1 2023 | $2,467,970 | -26.9% | 171,149 | -1.9% | 0.00% | 0.0% |
| Q4 2022 | $3,374,486 | -42.2% | 174,392 | +2.7% | 0.00% | 0.0% |
| Q3 2022 | $5,835,000 | +268.6% | 169,878 | +64.0% | 0.00% | – |
| Q2 2022 | $1,583,000 | -40.1% | 103,556 | -10.6% | 0.00% | -100.0% |
| Q1 2022 | $2,642,000 | -9.5% | 115,787 | +46.3% | 0.00% | 0.0% |
| Q4 2021 | $2,918,000 | +10.4% | 79,135 | +40.7% | 0.00% | 0.0% |
| Q3 2021 | $2,644,000 | – | 56,258 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $167,683,000 | 9.10% |
| ARCH Venture Management, LLC | 2,508,809 | $38,335,000 | 4.67% |
| Casdin Capital, LLC | 3,138,167 | $47,951,000 | 4.05% |
| M28 Capital Management LP | 178,500 | $2,727,000 | 3.06% |
| Redmile Group, LLC | 1,833,547 | $28,017,000 | 1.07% |
| Cormorant Asset Management, LP | 700,710 | $10,707,000 | 0.81% |
| Novo Holdings A/S | 927,100 | $14,166,000 | 0.70% |
| Pinz Capital Management, LP | 51,800 | $792,000 | 0.54% |
| PFM Health Sciences, LP | 845,186 | $12,914,000 | 0.49% |
| Artal Group S.A. | 400,000 | $6,112,000 | 0.33% |